1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Eicosapentaenoic Acid (EPA)
5.1.2 Docosahexaenoic Acid (DHA)
5.2 By Concentration Type
5.2.1 High Concentrated
5.2.2 Medium Concentrated
5.2.3 Low Concentrated
5.3 By Form
5.3.1 Triglycerides
5.3.2 Ethyl Esters
5.4 By Source
5.4.1 Fish Oil
5.4.2 Algae Oil
5.4.3 Krill Oil
5.4.4 Other Sources
5.5 By Application
5.5.1 Infant Formulae
5.5.2 Dietary Supplements
5.5.3 Fortified Food and Beverages
5.5.4 Pharmaceuticals
5.5.5 Other Applications
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.1.4 Rest of North America
5.6.2 Europe
5.6.2.1 Spain
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Germany
5.6.2.5 Italy
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Singapore
5.6.3.5 Australia
5.6.3.6 Rest of Asia-Pacific
5.6.4 South America
5.6.4.1 Brazil
5.6.4.2 Argentina
5.6.4.3 Rest of South America
5.6.5 Middle East and Africa
5.6.5.1 South Africa
5.6.5.2 United Arab Emirates
5.6.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE
6.1 Market Share Analysis
6.2 Strategies Adopted by Players
6.3 Most Active Companies
6.4 Company Profiles
6.4.1 Koninklijke DSM N.V
6.4.2 KD Pharma Group
6.4.3 Archer Daniels Midland Company
6.4.4 Corbion N.V.
6.4.5 Novasep Holding SAS
6.4.6 Neptune Wellness Solutions
6.4.7 BASF SE
6.4.8 Clover Corporation Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned
 - Koninklijke DSM N.V
- KD Pharma Group
- Archer Daniels Midland Company
- Corbion N.V.
- Novasep Holding SAS
- Neptune Wellness Solutions
- BASF SE
- Clover Corporation Ltd